PillRx only · Tablet · Oral
Candesartan Cilexetil
Brands: Atacand · Candesartan Cilexetil
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US29 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$2.431
Latest avg · Jul 22, 2026
-66%
Since Jan 22, 2025
6
Active US suppliers
61%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
6.9K
Rx · 2026 Q1
364K
Units dispensed
-7%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 24 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 10 | SUPPLYING |
| Mylan Pharmaceuticals Inc. | unknown | 8 | SUPPLYING |
| Zydus Lifesciences Limited | unknown | 8 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 4 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Sep 13, 2021RECALLRecall (Class III): Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, W…
Failed Impurities/Degradation Specifications; out of specification for Related Compound — Recalling firm: Viatris — Product was distributed nationwide.